Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

Of course it is for therapeutics design, it's the literal last sentence of the abstract:

"In conclusion, NTD-RBD bsAbs offer promising potential for the design of resilient, next-generation antibody therapeutics against SARS-CoV-2 VOCs."



Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: